The fission yeast model for the lysosomal storage disorder Batten disease predicts disease severity caused by mutations in CLN3.

Disease Models & Mechanisms
Rebecca L HainesSara E Mole

Abstract

The function of the CLN3 protein, which is mutated in patients with the neurodegenerative lysosomal storage disorder Batten disease, has remained elusive since it was identified 13 years ago. Here, we exploited the Schizosaccharomyces pombe model to gain new insights into CLN3 function. We modelled all missense mutations of CLN3 in the orthologous protein Btn1p, as well as a series of targeted mutations, and assessed trafficking and the ability of the mutant proteins to rescue four distinct phenotypes of btn1Delta cells. Mutating the C-terminal cysteine residues of Btn1p caused it to be internalised into the vacuole, providing further evidence that this protein functions from pre-vacuole compartments. Mutations in the lumenal regions of the multi-spanning membrane protein, especially in the third lumenal domain which contains a predicted amphipathic helix, had the most significant impact on Btn1p function, indicating that these domains of CLN3 are functionally important. Only one mutant protein was able to rescue the cell curving phenotype (p.Glu295Lys), and since this mutation is associated with a very protracted disease progression, this phenotype could be used to predict the disease severity of novel mutations in CLN3. The a...Continue Reading

References

Jan 1, 1991·Methods in Enzymology·S MorenoP Nurse
Jan 1, 1996·Annual Review of Biochemistry·F L Zhang, P J Casey
Feb 1, 1997·Neuropediatrics·R K Pullarkat, G N Morris
Aug 1, 1997·American Journal of Human Genetics·P B MunroeS E Mole
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·D A Pearce, F Sherman
Apr 7, 1999·Molecular Genetics and Metabolism·D A Pearce, F Sherman
Apr 7, 1999·Molecular Genetics and Metabolism·D A PearceF Sherman
May 13, 1999·Nature Genetics·D A PearceF Sherman
Nov 28, 2001·European Journal of Biochemistry·J M HolopainenI Järvelä
Mar 5, 2003·Biochemical and Biophysical Research Communications·Subrata ChattopadhyayDavid A Pearce
Apr 23, 2003·FEBS Letters·Qinwen MaoBeverly L Davidson
Dec 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yoojin KimDavid A Pearce
Dec 31, 2003·Molecular Biology of the Cell·Aija KyttäläJ Paul Luzio
Dec 16, 2004·The Journal of Biological Chemistry·Aija KyttäläJ Paul Luzio
Oct 28, 2005·Human Molecular Genetics·Denia Ramirez-Montealegre, David A Pearce
Jan 21, 2006·The Journal of Biological Chemistry·Sergio Padilla-López, David A Pearce
May 23, 2006·The Journal of Biological Chemistry·Yi CaoSusan L Cotman
Jul 11, 2006·Biochimica Et Biophysica Acta·Eija SiintolaSara E Mole
Aug 31, 2006·Journal of Neuroscience Research·Kaisu LuiroAnu Jalanko
Oct 13, 2006·Annals of Neurology·Srinivas B NarayanMichael J Bennett
May 8, 2007·Biochemical and Biophysical Research Communications·Judith A Hobert, Glyn Dawson
Sep 18, 2007·Journal of Neurochemistry·Sandra PohlStephan Storch
Oct 30, 2007·Experimental Neurology·Attila D Kovács, David A Pearce
Apr 11, 2008·Experimental Neurology·Jonathan D Cooper

❮ Previous
Next ❯

Citations

May 6, 2015·Biochimica Et Biophysica Acta·Kiterie M E FallerMichael Bond
Jan 23, 2013·Biochimica Et Biophysica Acta·Michael BondClaire Russell
May 18, 2016·Mechanisms of Ageing and Development·Gernot FruhmannVanessa Franssens
Oct 28, 2019·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Christopher J MinnisTristan R McKay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Batten Disease

Batten Disease is a group of nervous system disorders known as neuronal ceroid lipofuscinosis. This feed focuses on neurobiological and neuropathological aspects of this disease.